Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2951 results

Clinical Trials / Jun 26, 2026

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trials / Jun 05, 2026

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
Biography / Aug 19, 2021

Vasant Narasimhan
Clinical Trials / Jan 31, 2025

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Clinical Trials / May 16, 2024

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Press release / Jul 02, 2026

Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

First gene replacement therapy in the EU for broad population with SMA, including children two years and older, teens and adults Fixed, one-time dose designed to replace the faulty SMN1 gene,…
Event calendar
Board of Directors
Biography / Aug 19, 2021

Charlotte Pamer-Wieser
Biography / Mar 07, 2023

John D. Young

‹ Previous page
1
…
15
16
17
18
19
20
21
…
296
› Next page